Meta Platforms Inc vs Zimmer Biomet Holdings Inc — how do they compare? Meta Platforms Inc trades at $641.75 (market cap $1.64T), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Meta Platforms Inc is far larger — about 94.5× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays the higher dividend (1.07%). Which is the better fit depends on your goals.
| META | ZBH | |
|---|---|---|
Market Cap | $1.64T | $17.36B |
Volume | 24,093,972 | — |
Sector | Media | Health |
52-Week High | $790.00 | $107.71 |
52-Week Low | $525.72 | $79.58 |
Enterprise Value | $1.65T | $24.40B |
Dividend Yield | 0.33% | 1.07% |
Signals from Pluang's Aura AI — not financial advice
META trades at $643.81, down 0.34% on the day, with a bullish technical outlook supported by moving averages and key resistance at $654. The company reported strong Q1 2026 earnings of $10.44 EPS, beating estimates, and maintains robust profitability with a 32.84% net income margin. Recent news highlights the launch of its Muse Spark AI model and a $21 billion deal with CoreWeave, driving positive sentiment.
The outlook remains positive with a consensus price target of $817.32, implying significant upside. Risks include ongoing litigation over youth addiction and high capital expenditures in AI. Analyst consensus is strongly bullish with 79% buy ratings, supported by institutional accumulation and solid cash flow growth.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Meta Platforms Inc., doing business as Meta and previously known as Facebook Inc. It's a company that acts as a parent platform for Facebook, Messenger, Instagram, Whatsapp, Oculus and other subsidiaries. Among these platforms, Facebook is the number one social media platform in terms of the number of active users.
Read more on META →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →